Institutional investors purchased a net $518.1 thousand shares of NBIX during the quarter ended September 2015 and now own 96.95% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBUS CIRCLE INVESTORS Bought 177.4 Thousand shares of Neurocrine Biosciences In...